Here's Why Polen Capital Sold its Exponent (EXPO) Shares
Polen Capital, an investment management firm, published its “Polen US SMID Company Growth Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.
Exponent Inc (EXPO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 379,297 | $34,694 | +87% | 0.02% |
| 2. | Renaissance Technologies Jim Simons | 194,900 | $17,828 | +542% | 0.02% |
| 3. | 185,880 | $17,002 | 0.07% | ||
| 4. | Driehaus Capital Richard Driehaus | 173,758 | $15,894 | +6% | 0.25% |
| 5. | Citadel Investment Group Ken Griffin | 172,567 | $15,785 | +650% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $110.89 | 9 | Officer | 12,017 | 2021-12-31 | Filing | |
| $108.83 | 10 | Officer | 12,508 | 2021-10-01 | Filing | |
| $86.23 | 12 | Officer | 13,373 | 2021-07-02 | Filing | |
| $93.90 | 12 | Officer | 13,911 | 2021-04-02 | Filing | |
| $110.89 | 26 | Officer | 29,724 | 2021-12-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $101.92 | 2,509 | Officer | 6,329 | 2022-08-22 | Filing | |
| $99.10 | 3,000 | Officer | 26,444 | 2022-08-12 | Filing | |
| $100.00 | 3,234 | Officer | 21,002 | 2022-08-12 | Filing | |
| $98.90 | 3,000 | Officer | 29,444 | 2022-08-08 | Filing | |
| $98.00 | 1,600 | Officer | 14,065 | 2022-08-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 64,030 | $5,856,825 | 0% | |
| 2. | 15,449 | $1,413,120 | 0% | |
| 3. | 7,789,728 | $712,527 | 0.02% | |
| 4. | 5,592,988 | $511,590 | 0.01% | |
| 5. | 4,349 | $397,762 | 0.13% |
News See All
Hedge Fund and Insider Trading News: Leon Cooperman, Graticule Asset Management, Blackwells Capital, AQR Capital Management, Maverick Capital, Bridgewater Associates, Rocket Pharmaceuticals Inc (RCKT), and More
From Citizen Kane, chairman of the board Bernstein quips, “it’s no trick to make a lot of money… if what you want to do is make a lot of money.” Downright laughable was Washington Post’s catchy...
Here is What Hedge Funds Think About Exponent, Inc. (EXPO)
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Is it Worth Investing in Exponent (EXPO)?
Harding Loevner, an investment management firm, published its “Global Small Companies Equity Fund” third-quarter 2021 investor letter – a copy of which can be downloaded here.
Exponent, Inc. (EXPO): Are Hedge Funds Right About This Stock?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of June.
Polen Capital: "Exponent (EXPO) Showed Durable Growth Through the Worst of the Pandemic"
Polen Capital, an investment management firm, published its “Polen U.S. SMID Company Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Were Hedge Funds Right About Exponent, Inc. (EXPO)?
In this article you are going to find out whether hedge funds think Exponent, Inc. (NASDAQ:EXPO) is a good investment right now.
Exponent, Inc. (EXPO): Hedge Funds Are Nibbling
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Did Hedge Funds Make The Right Call On Exponent, Inc. (EXPO) ?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Is Exponent, Inc. (EXPO) A Good Stock To Buy?
In this article we will take a look at whether hedge funds think Exponent, Inc. (NASDAQ:EXPO) is a good investment right now.
Billionaire Hedge Funds
